Bio-Techne Corp. buy melinda
Start price
21.11.17
/
50%
€7.45
Target price
30.11.17
€7.61
Performance (%)
2.23%
End price
30.11.17
€7.62
Summary
This prediction ended on 30.11.17 with a price of €7.62. With a performance of 2.23%, the BUY prediction by melinda for Bio-Techne Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio-Techne Corp. | 2.679% | 2.679% | -21.769% | -23.333% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% | 64.694% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% | 109.729% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% | 55.832% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% | 67.674% |
Comments by melinda for this prediction
In the thread Bio-Techne Corp. diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 30/11 Präsentation
Bio-Techne Corp. engagiert in der Entwicklung, Herstellung und Verkauf von Biotechnologie Reagenzien und Instrumente für die Forschung und markets.It klinische Diagnose ist in drei Segmente sind: Biotechnologie, Protein-Plattformen, und Diagnostics.